Titre : Erreurs innées du métabolisme lipidique

Erreurs innées du métabolisme lipidique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Motor Vehicles
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Erreurs innées du métabolisme lipidique : Questions médicales les plus fréquentes", "headline": "Erreurs innées du métabolisme lipidique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Erreurs innées du métabolisme lipidique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-12", "dateModified": "2025-05-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Erreurs innées du métabolisme lipidique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Erreurs innées du métabolisme", "url": "https://questionsmedicales.fr/mesh/D008661", "about": { "@type": "MedicalCondition", "name": "Erreurs innées du métabolisme", "code": { "@type": "MedicalCode", "code": "D008661", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome de Barth", "alternateName": "Barth Syndrome", "url": "https://questionsmedicales.fr/mesh/D056889", "about": { "@type": "MedicalCondition", "name": "Syndrome de Barth", "code": { "@type": "MedicalCode", "code": "D056889", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.224" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipidémie familiale mixte", "alternateName": "Hyperlipidemia, Familial Combined", "url": "https://questionsmedicales.fr/mesh/D006950", "about": { "@type": "MedicalCondition", "name": "Hyperlipidémie familiale mixte", "code": { "@type": "MedicalCode", "code": "D006950", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.450" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type I", "alternateName": "Hyperlipoproteinemia Type I", "url": "https://questionsmedicales.fr/mesh/D008072", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type I", "code": { "@type": "MedicalCode", "code": "D008072", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.465" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type II", "alternateName": "Hyperlipoproteinemia Type II", "url": "https://questionsmedicales.fr/mesh/D006938", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type II", "code": { "@type": "MedicalCode", "code": "D006938", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.481" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hypercholestérolémie familiale homozygote", "alternateName": "Homozygous Familial Hypercholesterolemia", "url": "https://questionsmedicales.fr/mesh/D000090542", "about": { "@type": "MedicalCondition", "name": "Hypercholestérolémie familiale homozygote", "code": { "@type": "MedicalCode", "code": "D000090542", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.481.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type III", "alternateName": "Hyperlipoproteinemia Type III", "url": "https://questionsmedicales.fr/mesh/D006952", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type III", "code": { "@type": "MedicalCode", "code": "D006952", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.483" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type IV", "alternateName": "Hyperlipoproteinemia Type IV", "url": "https://questionsmedicales.fr/mesh/D006953", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type IV", "code": { "@type": "MedicalCode", "code": "D006953", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.487" } } }, { "@type": "MedicalWebPage", "name": "Hyperlipoprotéinémie de type V", "alternateName": "Hyperlipoproteinemia Type V", "url": "https://questionsmedicales.fr/mesh/D006954", "about": { "@type": "MedicalCondition", "name": "Hyperlipoprotéinémie de type V", "code": { "@type": "MedicalCode", "code": "D006954", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.493" } } }, { "@type": "MedicalWebPage", "name": "Hypolipoprotéinémies", "alternateName": "Hypolipoproteinemias", "url": "https://questionsmedicales.fr/mesh/D007009", "about": { "@type": "MedicalCondition", "name": "Hypolipoprotéinémies", "code": { "@type": "MedicalCode", "code": "D007009", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hypoalphalipoprotéinémies", "alternateName": "Hypoalphalipoproteinemias", "url": "https://questionsmedicales.fr/mesh/D052456", "about": { "@type": "MedicalCondition", "name": "Hypoalphalipoprotéinémies", "code": { "@type": "MedicalCode", "code": "D052456", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Déficit en lécithine-cholestérol-acyl-transférase", "alternateName": "Lecithin Cholesterol Acyltransferase Deficiency", "url": "https://questionsmedicales.fr/mesh/D007863", "about": { "@type": "MedicalCondition", "name": "Déficit en lécithine-cholestérol-acyl-transférase", "code": { "@type": "MedicalCode", "code": "D007863", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330.500" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Tangier", "alternateName": "Tangier Disease", "url": "https://questionsmedicales.fr/mesh/D013631", "about": { "@type": "MedicalCondition", "name": "Maladie de Tangier", "code": { "@type": "MedicalCode", "code": "D013631", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Déficit en lécithine-cholestérol-acyl-transférase", "alternateName": "Lecithin Cholesterol Acyltransferase Deficiency", "url": "https://questionsmedicales.fr/mesh/D007863", "about": { "@type": "MedicalCondition", "name": "Déficit en lécithine-cholestérol-acyl-transférase", "code": { "@type": "MedicalCode", "code": "D007863", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330.500" } } }, { "@type": "MedicalWebPage", "name": "Maladie de Tangier", "alternateName": "Tangier Disease", "url": "https://questionsmedicales.fr/mesh/D013631", "about": { "@type": "MedicalCondition", "name": "Maladie de Tangier", "code": { "@type": "MedicalCode", "code": "D013631", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.330.750" } } }, { "@type": "MedicalWebPage", "name": "Hypobêtalipoprotéinémies", "alternateName": "Hypobetalipoproteinemias", "url": "https://questionsmedicales.fr/mesh/D006995", "about": { "@type": "MedicalCondition", "name": "Hypobêtalipoprotéinémies", "code": { "@type": "MedicalCode", "code": "D006995", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.440" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Abêtalipoprotéinémie", "alternateName": "Abetalipoproteinemia", "url": "https://questionsmedicales.fr/mesh/D000012", "about": { "@type": "MedicalCondition", "name": "Abêtalipoprotéinémie", "code": { "@type": "MedicalCode", "code": "D000012", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.440.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Abêtalipoprotéinémie", "alternateName": "Abetalipoproteinemia", "url": "https://questionsmedicales.fr/mesh/D000012", "about": { "@type": "MedicalCondition", "name": "Abêtalipoprotéinémie", "code": { "@type": "MedicalCode", "code": "D000012", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.500.440.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Lipidoses", "alternateName": "Lipidoses", "url": "https://questionsmedicales.fr/mesh/D008064", "about": { "@type": "MedicalCondition", "name": "Lipidoses", "code": { "@type": "MedicalCode", "code": "D008064", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.641" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Céroïdes-lipofuscinoses neuronales", "alternateName": "Neuronal Ceroid-Lipofuscinoses", "url": "https://questionsmedicales.fr/mesh/D009472", "about": { "@type": "MedicalCondition", "name": "Céroïdes-lipofuscinoses neuronales", "code": { "@type": "MedicalCode", "code": "D009472", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.641.509" } } }, { "@type": "MedicalWebPage", "name": "Syndrome de Sjögren-Larsson", "alternateName": "Sjogren-Larsson Syndrome", "url": "https://questionsmedicales.fr/mesh/D016111", "about": { "@type": "MedicalCondition", "name": "Syndrome de Sjögren-Larsson", "code": { "@type": "MedicalCode", "code": "D016111", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.641.723" } } } ] }, { "@type": "MedicalWebPage", "name": "Xanthomatose cérébrotendineuse", "alternateName": "Xanthomatosis, Cerebrotendinous", "url": "https://questionsmedicales.fr/mesh/D019294", "about": { "@type": "MedicalCondition", "name": "Xanthomatose cérébrotendineuse", "code": { "@type": "MedicalCode", "code": "D019294", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C18.452.648.398.925" } } } ], "about": { "@type": "MedicalCondition", "name": "Erreurs innées du métabolisme lipidique", "alternateName": "Lipid Metabolism, Inborn Errors", "code": { "@type": "MedicalCode", "code": "D008052", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Carlos R Ferreira", "url": "https://questionsmedicales.fr/author/Carlos%20R%20Ferreira", "affiliation": { "@type": "Organization", "name": "Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States; Rare Disease Institute, Children's National Health System, Washington, DC, United States." } }, { "@type": "Person", "name": "Clara D M van Karnebeek", "url": "https://questionsmedicales.fr/author/Clara%20D%20M%20van%20Karnebeek", "affiliation": { "@type": "Organization", "name": "Departments of Pediatrics and Clinical Genetics, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Department of Pediatrics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada. Electronic address: c.d.vankarnebeek@amstedarmumc.nl." } }, { "@type": "Person", "name": "Jerry Vockley", "url": "https://questionsmedicales.fr/author/Jerry%20Vockley", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, University of Pittsburgh School of Medicine, Department of Human Genetics, Graduate School of Public Health, Pittsburgh, Pennsylvania, USA." } }, { "@type": "Person", "name": "Andrea L Gropman", "url": "https://questionsmedicales.fr/author/Andrea%20L%20Gropman", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Children's National, Washington, DC 20010, USA." } }, { "@type": "Person", "name": "Sumreena Mansoor", "url": "https://questionsmedicales.fr/author/Sumreena%20Mansoor", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Shifa College of Medicine, Shifa Tameer-e-millat university, H-8/4, Islamabad, Pakistan. dr.sumreena@gmail.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Spinal injury rates and specific causation in motor vehicle collisions.", "datePublished": "2023-03-30", "url": "https://questionsmedicales.fr/article/37003164", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.aap.2023.107047" } }, { "@type": "ScholarlyArticle", "name": "Lesson from the continuing 21st century motor vehicle success.", "datePublished": "2022-07-05", "url": "https://questionsmedicales.fr/article/35790347", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/ip-2022-044635" } }, { "@type": "ScholarlyArticle", "name": "Ambient temperature and risk of motor vehicle crashes: A countrywide analysis in Spain.", "datePublished": "2022-10-18", "url": "https://questionsmedicales.fr/article/36270536", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.envres.2022.114599" } }, { "@type": "ScholarlyArticle", "name": "A Systematic Review of the Risks of Motor Vehicle Crashes Associated with Psychiatric Disorders.", "datePublished": "2022-10-05", "url": "https://questionsmedicales.fr/article/36198019", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/07067437221128468" } }, { "@type": "ScholarlyArticle", "name": "Effect of eco-driving on commercial motor vehicle driver collision risk.", "datePublished": "2024-03-08", "url": "https://questionsmedicales.fr/article/38858043", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jsr.2024.02.013" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies métaboliques et nutritionnelles", "item": "https://questionsmedicales.fr/mesh/D009750" }, { "@type": "ListItem", "position": 3, "name": "Maladies métaboliques", "item": "https://questionsmedicales.fr/mesh/D008659" }, { "@type": "ListItem", "position": 4, "name": "Erreurs innées du métabolisme", "item": "https://questionsmedicales.fr/mesh/D008661" }, { "@type": "ListItem", "position": 5, "name": "Erreurs innées du métabolisme lipidique", "item": "https://questionsmedicales.fr/mesh/D008052" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Erreurs innées du métabolisme lipidique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Erreurs innées du métabolisme lipidique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Erreurs innées du métabolisme lipidique", "description": "Comment diagnostique-t-on une erreur métabolique lipidique ?\nQuels tests sont utilisés pour le diagnostic ?\nLes symptômes aident-ils au diagnostic ?\nQuelle est l'importance de l'histoire familiale ?\nPeut-on utiliser l'imagerie pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Motor+Vehicles&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Erreurs innées du métabolisme lipidique", "description": "Quels sont les symptômes courants ?\nLes symptômes varient-ils selon le type d'erreur ?\nY a-t-il des signes cutanés associés ?\nLes symptômes apparaissent-ils à la naissance ?\nLes troubles mentaux sont-ils possibles ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Motor+Vehicles&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Erreurs innées du métabolisme lipidique", "description": "Peut-on prévenir ces erreurs ?\nLe conseil génétique est-il utile ?\nLes vaccinations sont-elles importantes ?\nLes tests prénataux sont-ils recommandés ?\nL'éducation des parents est-elle cruciale ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Motor+Vehicles&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Erreurs innées du métabolisme lipidique", "description": "Quels traitements sont disponibles ?\nLa diététique joue-t-elle un rôle ?\nDes médicaments sont-ils utilisés ?\nLa thérapie génique est-elle une option ?\nLes greffes d'organes sont-elles nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Motor+Vehicles&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Erreurs innées du métabolisme lipidique", "description": "Quelles complications peuvent survenir ?\nLes erreurs lipidique peuvent-elles être mortelles ?\nY a-t-il des risques de cancer ?\nLes troubles psychologiques sont-ils fréquents ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Motor+Vehicles&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Erreurs innées du métabolisme lipidique", "description": "Quels sont les facteurs de risque génétiques ?\nL'origine ethnique influence-t-elle le risque ?\nL'alimentation joue-t-elle un rôle ?\nLes infections peuvent-elles aggraver la condition ?\nLe sexe influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Motor+Vehicles&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une erreur métabolique lipidique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, des analyses génétiques et des biopsies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de dépistage néonatal, des dosages enzymatiques et des analyses d'urine sont courants." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques orientent le diagnostic et peuvent indiquer le type d'erreur." } }, { "@type": "Question", "name": "Quelle est l'importance de l'histoire familiale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'histoire familiale aide à identifier les risques génétiques et à orienter les tests." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à évaluer les organes affectés, mais n'est pas spécifique." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleurs abdominales, troubles neurologiques et retard de croissance." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type d'erreur ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque type d'erreur lipidique présente des symptômes spécifiques et variés." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines erreurs peuvent provoquer des dépôts lipidiques visibles sur la peau." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils à la naissance ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Certains symptômes peuvent apparaître dès la naissance, d'autres se développent plus tard." } }, { "@type": "Question", "name": "Les troubles mentaux sont-ils possibles ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs et comportementaux peuvent survenir dans certaines erreurs." } }, { "@type": "Question", "name": "Peut-on prévenir ces erreurs ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est limitée, mais le dépistage néonatal peut aider à identifier les cas précoces." } }, { "@type": "Question", "name": "Le conseil génétique est-il utile ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le conseil génétique aide les familles à comprendre les risques et les options de dépistage." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne préviennent pas les erreurs métaboliques, mais protègent contre d'autres maladies." } }, { "@type": "Question", "name": "Les tests prénataux sont-ils recommandés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des tests prénataux peuvent être proposés pour détecter certaines erreurs génétiques." } }, { "@type": "Question", "name": "L'éducation des parents est-elle cruciale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les parents sur les signes et symptômes peut aider à une détection précoce." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des régimes alimentaires spécifiques, des suppléments et des médicaments." } }, { "@type": "Question", "name": "La diététique joue-t-elle un rôle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un régime adapté est crucial pour gérer les niveaux de lipides et prévenir les complications." } }, { "@type": "Question", "name": "Des médicaments sont-ils utilisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour réduire les niveaux de lipides ou traiter les symptômes." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche pour certaines erreurs, mais n'est pas encore courante." } }, { "@type": "Question", "name": "Les greffes d'organes sont-elles nécessaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas graves, des greffes peuvent être envisagées pour traiter des dommages organiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des maladies hépatiques, des troubles neurologiques et des problèmes cardiaques." } }, { "@type": "Question", "name": "Les erreurs lipidique peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines erreurs peuvent entraîner des complications graves pouvant être fatales sans traitement." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines erreurs peuvent augmenter le risque de développer certains types de cancer." } }, { "@type": "Question", "name": "Les troubles psychologiques sont-ils fréquents ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles psychologiques peuvent survenir en raison de l'impact des symptômes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes sans traitement." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque génétiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux d'erreurs métaboliques augmentent le risque de transmission." } }, { "@type": "Question", "name": "L'origine ethnique influence-t-elle le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines erreurs sont plus fréquentes dans des populations spécifiques en raison de la génétique." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation déséquilibrée peut exacerber les symptômes chez les individus prédisposés." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver la condition ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent déclencher ou aggraver les symptômes des erreurs métaboliques." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines erreurs métaboliques peuvent avoir une prévalence différente selon le sexe." } } ] } ] }

Sous-catégories

18 au total
└─

Syndrome de Barth

Barth Syndrome D056889 - C18.452.648.398.224
└─

Hyperlipidémie familiale mixte

Hyperlipidemia, Familial Combined D006950 - C18.452.648.398.450
└─

Hyperlipoprotéinémie de type I

Hyperlipoproteinemia Type I D008072 - C18.452.648.398.465
└─

Hyperlipoprotéinémie de type II

Hyperlipoproteinemia Type II D006938 - C18.452.648.398.481
└─

Hyperlipoprotéinémie de type III

Hyperlipoproteinemia Type III D006952 - C18.452.648.398.483
└─

Hyperlipoprotéinémie de type IV

Hyperlipoproteinemia Type IV D006953 - C18.452.648.398.487
└─

Hyperlipoprotéinémie de type V

Hyperlipoproteinemia Type V D006954 - C18.452.648.398.493
└─

Hypolipoprotéinémies

Hypolipoproteinemias D007009 - C18.452.648.398.500
└─

Lipidoses

Lipidoses D008064 - C18.452.648.398.641
└─

Xanthomatose cérébrotendineuse

Xanthomatosis, Cerebrotendinous D019294 - C18.452.648.398.925
└─└─

Hypercholestérolémie familiale homozygote

Homozygous Familial Hypercholesterolemia D000090542 - C18.452.648.398.481.500
└─└─

Hypoalphalipoprotéinémies

Hypoalphalipoproteinemias D052456 - C18.452.648.398.500.330
└─└─

Hypobêtalipoprotéinémies

Hypobetalipoproteinemias D006995 - C18.452.648.398.500.440
└─└─

Céroïdes-lipofuscinoses neuronales

Neuronal Ceroid-Lipofuscinoses D009472 - C18.452.648.398.641.509
└─└─

Syndrome de Sjögren-Larsson

Sjogren-Larsson Syndrome D016111 - C18.452.648.398.641.723
└─└─└─

Déficit en lécithine-cholestérol-acyl-transférase

Lecithin Cholesterol Acyltransferase Deficiency D007863 - C18.452.648.398.500.330.500
└─└─└─

Maladie de Tangier

Tangier Disease D013631 - C18.452.648.398.500.330.750
└─└─└─

Abêtalipoprotéinémie

Abetalipoproteinemia D000012 - C18.452.648.398.500.440.500

Sources (10000 au total)

Ambient temperature and risk of motor vehicle crashes: A countrywide analysis in Spain.

Some studies have documented that cold or hot ambient temperatures increase the risk of motor vehicle crashes. However, the number of existing studies is still limited, especially for the effects of c... To estimate the relationship between ambient temperatures and risk of motor vehicle crashes in Spain, and to estimate the same association when restricting to those crashes with driver performance-ass... We used data for the period 1993-2013. We conducted a time series analysis controlling for seasonality and trends and using the distributed lag nonlinear model framework to estimate nonlinear and dela... The study included 1,908,460 motor vehicle crashes, 37% of them with associated driver performance factors. The overall analysis showed that the risk of crashes increased almost linearly with temperat... The increase of temperature increased the risk of motor vehicle crashes in Spain. Measures aimed at reducing the influence of heat on the risk of motor vehicle crashes can have important benefits for ...

A Systematic Review of the Risks of Motor Vehicle Crashes Associated with Psychiatric Disorders.

Psychiatric disorders and their treatments have the potential to adversely impact driving skills. However, it is unclear to what extent this poses a public health risk by increasing the risk of motor ... We conducted a systematic review of the MVC risk associated with psychiatric disorders using seven databases in November 2019. Two reviewers examined each study and extracted data. The National Heart,... We identified 24 studies that met the inclusion criteria, including eight cohort, 10 case-control, and six cross-sectional designs. Quality assessment ratings were "Good" for four studies, "Fair" for ... The available evidence is mixed, not of high quality, and does not support a blanket restriction on drivers with psychiatric disorder. An individualized approach, as recommended by international guide...

Effect of eco-driving on commercial motor vehicle driver collision risk.

This study investigates the effect among commercial motor vehicle (CMV) drivers of the adoption of fuel-efficient driving techniques (commonly known as eco-driving) on the odds of being involved in sa... For 2,637 long-haul class 8 drivers employed by four carriers in Canada, information on driving style, total distance driven, and safety-related events like collisions, hard-braking, hard-turning, and... A one-unit increase in the ISAAC score was associated with a 7%, 8%, 8%, and 4% reduction in the odds of having a hard-braking event, hard left-turn event, hard right-turn event, and collision, respec...

Catastrophic health expenditure in nonneurological injury due to motor vehicle crash.

Motor vehicle crashes (MVCs) are a leading cause of nonfatal injury in the United States and impose a high financial cost to the patient and the economy. For many patients, this cost may be financiall... We performed a retrospective review using the 2014-2017 Nationwide Inpatient Sample. The study population consisted of uninsured and privately insured adults aged 26 to 64 years who were hospitalized ... Our sample included 189,000 patients, of which 149,705 had private insurance and 39,375 were uninsured. The median estimated income for the study cohort was $66,118 (interquartile range, $65,353-$66,8... Nine of 10 uninsured patients are at risk for CHE after hospitalization for MVC. Despite having insurance, 10% of patients are still at risk of CHE. Black, Hispanic, and low-income communities are at ... Prognostic and Epidemiological; Level III....

Assessing the Impact of Hands-Free Georgia on Serious Motor Vehicle Accidents.

Hands-Free Georgia Law (HB673) was designed to prevent motor vehicle collisions (MVCs) by banning drivers from using their hands for non-driving-related activities, including cell phone use. We invest... The Georgia Trauma Registry (GTR) was queried for MVCs from 2017 to 2019, representing the 18 months prior and following implementation of HB673. The number of MVCs for each period and severity of MVC... Prior to implementation, a total of 43 080 traumas were recorded in GTR, 11 111 (25.8%) were attributed to an MVC. Following implementation, 12 130 (23.6%) occurred secondary to MVCs. Statewide MVC-re... The Hands-Free Georgia Law seems to have not had a major reduction in mortality in its early implementation....

Inequalities in alcohol consumption and cell phone use while driving motor vehicles.

To evaluate social inequalities of Brazilians in alcohol consumption and cell phone use while driving motor vehicles.... Cross-sectional study conducted with people who drive (n=23,474) in 2019. The outcomes adopted were cell phone use and alcohol consumption while driving, associated with the variables gender, age grou... The inequalities related to alcohol consumption and driving were identified in adults with brown skin color (7.8) linked to the North region (6.8). As for cell phone use while driving, they were highe... Cell phone use and alcohol consumption while driving motor vehicles have social inequalities regarding the age group and education, and skin color and macro-region respectively....